Cappel Mark, Mauger David, Thiboutot Diane
Department of Internal Medicine, The Medical College of Wisconsin, Milwauke, USA.
Arch Dermatol. 2005 Mar;141(3):333-8. doi: 10.1001/archderm.141.3.333.
To determine if insulin-like growth factor 1 (IGF-1) and androgen levels (1) correlate with the presence and severity of acne in adult men and women, and (2) correlate directly with each other and interact in affecting acne.
Case-control study and single-center examination of hormone levels in a cohort of volunteers.
Academic referral center.
Thirty-four subjects (8 women and 8 men with clinical acne, 10 women and 8 men without clinical acne). Clinical acne is defined by a history of persistent acne (acne present on most days for several years), recent acne treatment, and the presence of 10 or more inflammatory acne lesions and 15 or more comedones.
Single visit for serum sampling.
Serum levels of IGF-1 and androgens were determined, adjusted for age, and compared based on the presence or absence of clinical acne using an analysis of covariance. Correlations between hormone levels and acne lesion counts were calculated within each subgroup. Correlations were also calculated between serum levels of IGF-1 and androgens. Further statistical testing was conducted to determine whether IGF-1 or androgens had a greater effect on acne lesion counts.
Dehydroepiandrosterone (DHEAS), dihydrotestosterone (DHT), and IGF-1 correlated positively with acne lesion counts in women. Androstenedione and DHEAS correlated with acne lesion counts in men. Although the age-adjusted mean serum levels of IGF-1 were higher in women with clinical acne than in women without clinical acne, this difference did not achieve statistical significance. No difference in IGF-1 level was noted in men based on the presence of clinical acne. In women with clinical acne, IGF-1 correlated with DHT. In men with clinical acne, IGF-1 correlated with DHEAS and androstenedione. In men and women with clinical acne, the effects of androgens on increased acne lesion counts were dependent on the influence of IGF-1.
Increased IGF-1 levels in addition to androgens may influence acne in adult men and women. While IGF-1 appears to have a stronger effect on acne in women, androgens may play a greater role in acne for men. However, in both men and women these hormones are interrelated, possibly owing to reciprocal effects on hormone production.
确定胰岛素样生长因子1(IGF-1)和雄激素水平(1)是否与成年男性和女性痤疮的存在及严重程度相关,以及(2)是否彼此直接相关并在影响痤疮方面相互作用。
病例对照研究及对一组志愿者进行单中心激素水平检测。
学术转诊中心。
34名受试者(8名患有临床痤疮的女性和8名男性,10名无临床痤疮的女性和8名男性)。临床痤疮定义为有持续性痤疮病史(数年中多数日子有痤疮)、近期接受痤疮治疗,且有10个或更多炎性痤疮皮损及15个或更多粉刺。
单次就诊进行血清采样。
测定血清IGF-1和雄激素水平,根据年龄进行校正,并使用协方差分析,基于有无临床痤疮进行比较。在每个亚组内计算激素水平与痤疮皮损计数之间的相关性。还计算了血清IGF-1和雄激素水平之间的相关性。进行进一步的统计学检验以确定IGF-1或雄激素对痤疮皮损计数的影响是否更大。
脱氢表雄酮(DHEAS)、双氢睾酮(DHT)和IGF-1与女性痤疮皮损计数呈正相关。雄烯二酮和DHEAS与男性痤疮皮损计数相关。虽然患有临床痤疮的女性经年龄校正后的IGF-1平均血清水平高于无临床痤疮的女性,但这种差异无统计学意义。基于有无临床痤疮,男性的IGF-1水平未发现差异。在患有临床痤疮的女性中,IGF-1与DHT相关。在患有临床痤疮的男性中,IGF-1与DHEAS和雄烯二酮相关。在患有临床痤疮的男性和女性中,雄激素对痤疮皮损计数增加的影响取决于IGF-1的影响。
除雄激素外,IGF-1水平升高可能影响成年男性和女性的痤疮。虽然IGF-1似乎对女性痤疮的影响更强,但雄激素在男性痤疮中可能起更大作用。然而,在男性和女性中,这些激素相互关联,可能是由于对激素产生的相互影响。